Sign up to save your podcasts
Or
Share Funding the future of retinal health with Eyepoint
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Funding the future of retinal health with Eyepoint
Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence.
View all episodes
By RBC Capital Markets
5
1212 ratings
Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence.
More shows like Pathfinders in Biopharma
View all
Motley Fool Money
3,220 Listeners
WSJ Your Money Briefing
1,707 Listeners
Exchanges
965 Listeners
Odd Lots
1,944 Listeners
WSJ Tech News Briefing
1,646 Listeners
The a16z Show
1,087 Listeners
The Long Run with Luke Timmerman
125 Listeners
The Readout Loud
321 Listeners
Wall Street Breakfast
1,039 Listeners
Thoughts on the Market
1,298 Listeners
The Journal.
6,078 Listeners
BioCentury This Week
34 Listeners
RBC's Markets in Motion
40 Listeners
Biotech Hangout
19 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Markets
81 Listeners
Strategic Alternatives
18 Listeners
The Top Line
13 Listeners
Macro Minutes
3 Listeners